Provigil users may be eligible in settlement

December 21, 2016

Idahoans who bought the wakefulness drug Provigil may be eligible for part of a $35 million settlement. Consumers who purchased generic versions may also be eligible. Idaho Attorney General Lawrence Wasden announced in August a settlement with Cephalon, Inc. and its affiliated companies. The settlement included Idaho and 47 other states who filed a lawsuit asserting the manufacturer violated antitrust laws. Affected consumers could submit claims beginning this week. Those who purchased Provigil® and/or generic versions of Provigil® (modafinil) between June 24, 2006, and March 31, 2012, may be entitled to a payment. To learn more about the settlement, and to submit a consumer claim form, consumers can now visit www.stateagprovigilsettlement.com. To be eligible to receive a payment, consumers must complete and submit a valid claim form by April 13, 2017.